Characterization and antitumor efficacy of poly(L-lactid acid)-based etoposide-loaded implants

References

• Ardizzoni A, Antonelli G, Grossi F, et al. (1999). The combination of etoposide and cisplatin in non-small-cell lung cancer (NSCLC). Ann Oncol 10(Suppl 5):S13–17
   PubMed Web of Science ®Google Scholar
• Arriagada R, Bergman B, Dunant A, et al. (2004). Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350:351–60
   PubMed Web of Science ®Google Scholar
• Athawale RB, Jain DS, Singh KK, Gude RP. (2014). Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung. Biomed Pharmacother 68:231–40
   PubMed Web of Science ®Google Scholar
• Bauquier SH, Mclean KJ, Jiang JL, et al. (2016). Evaluation of the biocompatibility of polypyrrole implanted subdurally in GAERS. Macromol Biosci. doi:10.1002/mabi.201600334
   PubMed Web of Science ®Google Scholar
• Bergstrom JS, Hayman D. (2016). An overview of mechanical properties and material modeling of polylactide (PLA) for medical applications. Ann Biomed Eng 44:330–40
   PubMed Web of Science ®Google Scholar
• Chen L, Tan L, Zhang X, et al. (2015). Which polymer is more suitable for etoposide: A comparison between two kinds of drug loaded polymeric micelles in vitro and in vivo?. Int J Pharm 495:265–75
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. (2016). Cancer statistics in China, 2015. CA Cancer J Clin 66:115–32
   PubMed Web of Science ®Google Scholar
• Cheng L, Lei L, Guo S. (2010). In vitro and in vivo evaluation of praziquantel loaded implants based on PEG/PCL blends. Int J Pharm 387:129–38
   PubMed Web of Science ®Google Scholar
• Committee NP. 2015. Pharmacopoeia of the People's Republic of China Beijing: China Medical Science Press
   Google Scholar
• Dong W, Zhang L, Niu Y, et al. (2013). A stable and practical etoposide-containing intravenous long-/medium-chain triglycerides-based lipid emulsion formulation: pharmacokinetics, biodistribution, toxicity, and antitumor efficacy. Expert Opin Drug Deliv 10:559–71
   PubMed Web of Science ®Google Scholar
• Dong Y, Chin SF, Blanco E, et al. (2009). Intratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapy. Clin Cancer Res 15:131–9
   PubMed Web of Science ®Google Scholar
• El-Badry M, Fetih G, Fathy M. (2009). Improvement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG4000. Saudi Pharm J 17:217–25
   PubMedGoogle Scholar
• Ezoe S. (2012). Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor. Int J Environ Res Public Health 9:2444–53
   PubMed Web of Science ®Google Scholar
• Gardella L, Colonna S, Fina A, Monticelli O. (2016). A novel electrostimulated drug delivery system based on PLLA composites exploiting the multiple functions of graphite nanoplatelets. ACS Appl Mater Interfaces 8:24909–17
   PubMed Web of Science ®Google Scholar
• Hande KR. (1996). The importance of drug scheduling in cancer chemotherapy: etoposide as an example. Oncologist 1:234–9
   PubMedGoogle Scholar
• Hande KR. (1998). Etoposide: four decades of development of a topoisomerase II inhibitor. Eur J Cancer 34:1514–21
   PubMed Web of Science ®Google Scholar
• Heldin CH, Rubin K, Pietras K, Ostman A. (2004). High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer 4:806–13
   PubMed Web of Science ®Google Scholar
• Hussein KH, Park KM, Kang KS, Woo HM. (2016). Biocompatibility evaluation of tissue-engineered decellularized scaffolds for biomedical application. Mater Sci Eng C Mater Biol Appl 67:766–78
   PubMed Web of Science ®Google Scholar
• Kreye F, Siepmann F, Siepmann J. (2011). Drug release mechanisms of compressed lipid implants. Int J Pharm 404:27–35
   PubMed Web of Science ®Google Scholar
• Krukiewicz K, Zak JK. (2016). Biomaterial-based regional chemotherapy: Local anticancer drug delivery to enhance chemotherapy and minimize its side-effects. Mater Sci Eng C Mater Biol Appl 62:927–42
   PubMed Web of Science ®Google Scholar
• Liltorp K, Larsen TG, Willumsen B, Holm R. (2011). Solid state compatibility studies with tablet excipients using non thermal methods. J Pharm Biomed Anal 55:424–8
   PubMed Web of Science ®Google Scholar
• Liu W, Wei J, Huo P, et al. (2013). Controlled release of brefeldin A from electrospun PEG-PLLA nanofibers and their in vitro antitumor activity against HepG2 cells. Mater Sci Eng C Mater Biol Appl 33:2513–18
   PubMed Web of Science ®Google Scholar
• Loo SC, Tan ZY, Chow YJ, Lin SL. (2010). Drug release from irradiated PLGA and PLLA multi-layered films. J Pharm Sci 99:3060–71
   PubMed Web of Science ®Google Scholar
• Maswadeh HM, Aljarbou AN, Alorainy MS, et al. (2015). Etoposide incorporated into camel milk phospholipids liposomes shows increased activity against fibrosarcoma in a mouse model. Biomed Res Int 2015:743051
   PubMed Web of Science ®Google Scholar
• Najar IA, Johri RK. (2014). Pharmaceutical and pharmacological approaches for bioavailability enhancement of etoposide. J Biosci 39:139–44
   PubMed Web of Science ®Google Scholar
• Saltzman WM, Fung LK. (1997). Polymeric implants for cancer chemotherapy. Adv Drug Deliv Rev 26:209–30
   PubMed Web of Science ®Google Scholar
• Shen YY, Qin HW, Zhang JB, et al. (2016). Fluorouracil implants caused a diaphragmatic tumor to be misdiagnosed as liver metastasis: a case report. BMC Cancer 16:754
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. (2016). Cancer statistics, 2016. CA Cancer J Clin 66:7–30
   PubMed Web of Science ®Google Scholar
• Skalickova S, Nejdl L, Kudr J, et al. (2016). Fluorescence Characterization of Gold Modified Liposomes with Antisense N-myc DNA Bound to the Magnetisable Particles with Encapsulated Anticancer Drugs (Doxorubicin, Ellipticine and Etoposide). Sensors (Basel) 16:290
   PubMed Web of Science ®Google Scholar
• Solano AG, De Fatima Pereira A, Pinto FC, et al. (2013). Development and evaluation of sustained-release etoposide-loaded poly(epsilon-caprolactone) implants. AAPS PharmSciTech 14:890–900
   PubMed Web of Science ®Google Scholar
• Strickley RG. (2004). Solubilizing excipients in oral and injectable formulations. Pharm Res 21:201–30
   PubMed Web of Science ®Google Scholar
• Tang BC, Fu J, Watkins DN, et al. (2010). Enhanced efficacy of local etoposide delivery by poly(ether-anhydride) particles against small cell lung cancer in vivo. Biomaterials 31:339–44
   PubMed Web of Science ®Google Scholar
• Ukawala M, Rajyaguru T, Chaudhari K, et al. (2012). Investigation on design of stable etoposide-loaded PEG-PCL micelles: effect of molecular weight of PEG-PCL diblock copolymer on the in vitro and in vivo performance of micelles. Drug Deliv 19:155–67
   PubMed Web of Science ®Google Scholar
• Upadhyay P, Nayak K, Patel K, et al. (2014). Formulation development, optimization, and evaluation of sustained-release tablet of valacyclovir hydrochloride by combined approach of floating and swelling for better gastric retention. Drug Deliv Transl Res 4:452–64
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Hassanzadeh F, Sadeghi-Aliabadi H, et al. (2014). Uptake of etoposide in CT-26 cells of colorectal cancer using folate targeted dextran stearate polymeric micelles. Biomed Res Int 2014:708593
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang X, Zhang L, et al. (2015a). Development of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral release. Drug Deliv 22:389–99
   PubMed Web of Science ®Google Scholar
• Wang Z, Li Z, Zhang D, et al. (2015b). Development of etoposide-loaded bovine serum albumin nanosuspensions for parenteral delivery. Drug Deliv 22:79–85
   PubMed Web of Science ®Google Scholar
• Weinberg BD, Blanco E, Gao J. (2008). Polymer implants for intratumoral drug delivery and cancer therapy. J Pharm Sci 97:1681–702
   PubMed Web of Science ®Google Scholar
• Wolinsky JB, Colson YL, Grinstaff MW. (2012). Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. J Control Release 159:14–26
   PubMed Web of Science ®Google Scholar
• Wu G, Wu W, Zheng Q, et al. (2014). Experimental study of PLLA/INH slow release implant fabricated by three dimensional printing technique and drug release characteristics in vitro. Biomed Eng Online 13:97
   PubMed Web of Science ®Google Scholar
• Xu H, Deshmukh R, Timmons R, et al. (2011). Enhanced endothelialization on surface modified poly(L-lactic acid) substrates. Tissue Eng Part A 17:865–76
   PubMed Web of Science ®Google Scholar
• Zhang S, Lu C, Zhang X, et al. (2016). Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system. Drug Deliv 23:1838–45
   PubMed Web of Science ®Google Scholar